Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for HIVE. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: HIVE is a Strong Sell candidate.
HIVE stock price ended at $0.073105 on 星期日, after dropping 2.34%
On Feb 08, 2026 00:00, the price of HIVE fell by 2.34%, dropping from $0.073601 to $0.073105 with 24h trading volume reaching $1.8M HIVE.
